UPC APP 8500/2024
EP2697391 · METHOD AND PRODUCT FOR LOCALISED OR SPATIAL DETECTION OF NUCLEIC ACID IN A TISSUE SAMPLE
- Case details
- Status—Action—CategoryOther procedural
- Parties
- Claimants
- Curio Bioscience Inc.Operating co.
Representatives- Agathe Michel-De Cazotte-Carpmaels & Ransford
- Cameron Marschall-Carpmaels & Ransford
Respondents- 10x Genomics, Inc.Operating co.
Representatives- Tilman Müller-Stoy-Bardehle Pagenberg
- Martin Drews-Bardehle Pagenberg
- Axel Berger-Bardehle Pagenberg
- Division
- —
- Judges
- —
- Technology
- ChemistryBiotechnology
- Language
- —
| Median days to first decision | |
|---|---|
| All UPC | 124 |
At the UPC: Curio Bioscience Inc. (19 cases)·10x Genomics, Inc. (40 cases)
This dispute contains 18 other proceedings
UPC CFI 657/2025·UPC CFI 658/2025·UPC CoA 805/2024·UPC CoA 810/2024·UPC CoA 234/2024 and 13 more
Start a free trial to see how each one ended.
More cases: 2024
- 2024-03-11Application for provisional measuresPublic
Summary: The Düsseldorf Local Division issued a confidentiality protection order under R.262A RoP establishing principles for granting natural persons access to protected information, holding that access cannot be denied solely because a named person works in the relevant technical field.
Show the legal issues (2)
- scope of access to confidential information R.262A.6 RoP
- right to fair trial vs trade secret protection
- 2024-02-23Application for provisional measuresPublic
Summary: Published headnotes and keywords document for the 23 February 2024 Düsseldorf Local Division order in Curio Bioscience v. 10x Genomics, setting out the legal principles on trade secret protection under Rule 262A RoP in provisional measures proceedings, including preliminary access restrictions and the right to be heard before a final confidentiality order.
Show the legal issues (4)
- Rule 262A RoP: confidentiality protection in provisional measures proceedings
- Preliminary access restrictions prior to final confidentiality order
- Rule 262A.4 RoP: right to be heard before final order
- Proportionate circle of persons with access to confidential information in interim proceedings
- 2024-02-23Application for provisional measuresPublic
Summary: The Düsseldorf Local Division issued a confidentiality protection order under Rule 262A RoP in Curio Bioscience v. 10x Genomics, establishing preliminary access restrictions to allegedly confidential documents and setting out the proportionate circle of persons entitled to access (four legal representatives, two patent attorneys, three client representatives, expandable by two paralegals if needed).
Show the legal issues (3)
- Rule 262A RoP: confidentiality protection order in provisional measures proceedings
- Proportionate access circle under Rule 262.6 RoP
- Preliminary access restrictions pending final confidentiality determination
- 2024-02-23%20LD%20D%C3%BCsseldorf%20UPC_CFI_463-2023%20ACT_590953-2023%20App_8500-2024%20Headnotes%20and%20Keywords.pdf2024-02-23DE
- 2024-02-23%20LD%20D%C3%BCsseldorf%20UPC_CFI_463-2023%20ACT_590953-2023%20App_8500-2024%20anonymized.pdf2024-02-23DE
- 2024-03-11%20LD%20Dusseldorf%20UPC_CFI_463-2023%20ORD_8550-2024%20App_8500-2024%20anonymized.pdf2024-03-11DE